Evidence map›Paper›PMID 42280196›Full record

ArticleMolecules (Basel, Switzerland)2026

Modeling Opposite Effects of an Additive on Liquid-Liquid Phase Separation and Crystal Solubility of Protein Solutions.

Onofrio Annunziata, Shamberia Thomas

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Onofrio AnnunziataDepartment of Chemistry and Biochemistry, Texas Christian University, Fort Worth, TX 76109, USA.ORCID 0000-0002-6636-4750
Shamberia ThomasDepartment of Chemistry and Biochemistry, Texas Christian University, Fort Worth, TX 76109, USA.

Funding

Texas Christian University RCAF 61038
6 · The paper itself

Abstract

In protein solutions, an additive that increases protein-protein attractive interactions is expected to decrease protein crystal solubility and raise the temperature at which liquid-liquid phase separation (LLPS) occurs. In contrast, addition of 0.10 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonate (HEPES) to lysozyme-NaCl aqueous solutions at constant pH (7.4) and ionic strength (0.20 M) decreases solubility but lowers the LLPS temperature. This leads to the broadening of the LLPS metastability gap in the phase diagram and an enhancement of protein crystallization yield from LLPS. We theoretically examine the effect of HEPES on both solubility and LLPS boundaries using a colloid model. Under the hypothesis that HEPES stabilizes protein-protein contacts in the crystal lattice by physical cross-linking, we apply cell theory to describe the thermodynamic behavior of the crystalline phase and use solubility data to show that HEPES increases protein-protein attraction energy by 2.7%. Since an increase in attraction incorrectly predicts a rise in the LLPS temperature, we consider that HEPES also enhances the anisotropic character of protein-protein interactions. To describe the thermodynamic behavior of the solution phase, we start from Barker-Henderson second-order perturbation theory on the hard-sphere reference fluid with square-well potential and local-compressibility approximation. We modify this model so that it can reproduce the correct mathematical expression of the second virial coefficient. This also leads to better agreement with Monte Carlo simulations. We then approximately incorporate anisotropy by assuming that the square-well attraction energy is a temperature-dependent average over all the surface of a particle with a given fractional coverage of attractive spots. The attraction energy of the attractive spots is set to be the same as that of the protein-protein contacts in the crystal. Only fractional coverage (anisotropy) was varied to successfully fit the effect of HEPES on the LLPS boundary.

Indexed as

HEPESMuramidaseProteinsCrystallizationPhase SeparationSolubilitySolutionsTemperatureThermodynamicsHEPESMuramidaseProteinsSolutionsanisotropyBarker–HendersonHEPESlysozymemetastabilityNaCl

Identifiers

PMID42280196
PMCPMC13258223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.